妊娠期高血压疾病患者产后使用非甾体抗炎药的安全性:系统综述与荟萃分析
结果显示NSAIDs未显著增加产后严重高血压风险(OR 1.52,95%CI 0.77-3.01),舒张压 marginally 降低(MD -2.28 mmHg,95%CI -4.44至-0.13),但证据质量极低。
要点
- 产后使用NSAIDs未显著增加妊娠期高血压疾病患者严重高血压风险。
- 收缩压和平均动脉压无显著差异,舒张压轻微降低。
- 证据质量极低,需大规模随机对照试验验证安全性。
核心结论
- 产后使用NSAIDs与妊娠期高血压疾病患者血压升高无关。
- 现有证据质量极低,未来需大规模随机对照试验验证。
研究设计与样本
- 纳入随机对照试验和队列研究,排除病例对照研究、病例系列和病例报告。
- 8项研究纳入定量荟萃分析,采用随机效应模型,证据质量按GRADE评估。
主要发现
- NSAIDs组与非NSAIDs组产后严重高血压风险无显著差异(OR 1.52,95%CI 0.77-3.01)。
- 产后收缩压无显著差异(MD -3.03 mmHg,95%CI -6.21至0.15 mmHg)。
- 产后平均动脉压无显著差异(MD -0.38 mmHg,95%CI -1.88至1.11 mmHg)。
- 产后舒张压在使用NSAIDs的女性中 marginally 更低(MD -2.28 mmHg,95%CI -4.44至-0.13 mmHg)。
- 亚组分析(大样本研究、随机对照试验、重度子痫前期、布洛芬与对乙酰氨基酚对照)结果一致。
关键数值与推荐
- 主要结局为严重高血压发生率及收缩压、舒张压和平均动脉压。
- GRADE评价证据可信度极低,因研究局限性、不一致性和不精确性。
临床怎么用
- 对于妊娠期高血压疾病产妇,产后使用NSAIDs镇痛可能不增加严重高血压风险。
- 临床决策需结合极低质量证据,个体化评估血压监测。
局限性
- 证据质量极低,存在研究局限性、不一致性和不精确性。
- 纳入研究数量有限,需未来大规模随机对照试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure when administered for postpartum analgesia in women with hypertensive disorders of pregnancy. METHODS: MEDLINE, Scopus, CENTRAL, Clinicaltrials.gov and Google Scholar databases were searched systematically from inception to 5 December 2019 for studies evaluating the safety of postpartum NSAIDs in women with any gestational hypertensive disorder. Randomized controlled trials (RCTs) and cohort studies were eligible for inclusion. Case-control studies, case series and case reports were excluded. The primary outcomes of interest were the incidence of severe hypertension and systolic, diastolic and mean arterial blood pressure. Pooled estimates were obtained by fitting a random-effects statistical model. The quality of evidence was assessed according to Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines. RESULTS: Ten studies were included, comprising five RCTs and five retrospective cohort studies and involving a total of 1647 women. All studies were evaluated qualitatively and eight of them were included in the quantitative meta-analysis. Administration of NSAIDs was not associated with a significantly higher risk of severe postpartum hypertension (odds ratio, 1.52 (95% CI, 0.77-3.01)). Similarly, no significant differences were found in postpartum systolic blood pressure (mean difference (MD), -3.03 mmHg (95% CI, -6.21 to 0.15 mmHg)) and mean arterial pressure (MD, -0.38 mmHg (95% CI, -1.88 to 1.11 mmHg)) between women who received NSAIDs and those who did not, whereas postpartum diastolic blood pressure was marginally lower in women treated with NSAIDs (MD, -2.28 mmHg (95% CI, -4.44 to -0.13 mmHg)). The same effects were observed when studies with a large sample size, RCTs, women with severe pre-eclampsia and studies using ibuprofen as the study drug and acetaminophen as the control treatment were examined separately. The credibility of evidence was judged to be very low according to GRADE, owing to concerns about study limitations, inconsistency and imprecision. CONCLUSIONS: This meta-analysis suggests that postpartum administration of NSAIDs is not associated with elevated blood pressure in women with hypertensive disorders of pregnancy. However, the existing evidence is of very low quality, thus future large-scale RCTs are warranted to verify the safety of postpartum NSAIDs in this population. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Bellos I, Pergialiotis V, Antsaklis A, et al. Safety of non-steroidal anti-inflammatory drugs in postpartum period in women with hypertensive disorders of pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2020. PMID: 32068930. doi:10.1002/uog.21997
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。